We will look at which medicines are being prescribed, how they are used over time, and how well they work for different groups of patients. This includes treatments like budesonide and 5-ASAs, which are commonly used to help control inflammation and maintain remission.
To better understand how these conditions are currently being treated in real-world settings. By identifying patterns in prescribing and outcomes, we can highlight what is working well and where improvements are needed. This means doctors will have better information to guide their decisions, helping them choose the most suitable treatments for each patient. It could also lead to updates in clinical guidelines and support more personalised care. This for patients may mean fewer relapses, better symptom control, and improved quality of life. It may also help reduce unnecessary treatments and avoid side effects from medicines that are not working as intended. Overall, the project aims to make IBD care safer, more effective, and more tailored to individual patients.
